Osteogenic Action of a Medical Device Based on Beta-tricalcium Phosphate (BTCP)

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 31, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

July 31, 2026

Conditions
Bone LossRegenerative InflammationThird Molars Extraction
Interventions
COMBINATION_PRODUCT

Medical device: beta-tricalcium phosphate

The description of the intervention for BTCP in the study involves the application of this substance to promote bone regeneration following the extraction of impacted mandibular third molars. BTCP is indicated for the treatment of segmental and cavitary bone loss, aesthetic repairs, and bone augmentations (such as inlay or onlay grafts); for filling dental alveolar bone; for dental implant placement; and for the stabilization of osteotomies and prostheses in dentistry.

OTHER

Bovine Hydroxyapatite

The intervention description for Bio-Oss in the study involves the application of this standard material to promote bone regeneration following the extraction of impacted mandibular third molars. Bio-Oss is a commonly used xenograft material known for its osteoconductive properties.

Trial Locations (2)

15705

Universidade de Santiago de Compostela, Santiago de Compostela

Unknown

University of Murcia, Murcia

All Listed Sponsors
collaborator

Universidad de Murcia

OTHER

collaborator

Nueva Galimplant SLU

UNKNOWN

lead

Mario Pérez Sayáns

OTHER

NCT06935747 - Osteogenic Action of a Medical Device Based on Beta-tricalcium Phosphate (BTCP) | Biotech Hunter | Biotech Hunter